Faculty

Institution

Unit

Venue

Aya Albittar

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneAya Albittar is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Aya Albittar

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology medicine pharmacology radiation oncology cancer research cancer care medicinal research cancer immunotherapy immunotherapy metastasis cancer management cancer treatment dermatology clinical epidemiology outcomes research clinical research cellular therapy pharmacotherapy medical mycology surgical oncology hematological malignancies systemic therapy breast oncology immune checkpoint inhibitors acute myeloid leukemia brain metastases cancer cells cardiovascular research respiratory medicine thoracic oncology preventive medicine clinical investigation strategic studies supportive care symptom management cancer discovery melanoma therapeutic vaccines cardiovascular toxicity cardiovascular pharmacology clinical evidence cancer risk pulmonary diseases clinical mycology cancer biology clinical immunology tumor suppressors anti-cancer agents tumor targeting tumor heterogeneity radiation therapy myeloid neoplasia anticancer treatments checkpoint inhibitors risk factors single center experience relapsed breast cancer exploratory study advanced cancer patients phase ib study metastatic melanoma

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase Ib Study of Selinexor in Combination With Pembrolizumab in Patients With Metastatic Melanoma. Journal of Immunotherapy and Precision Oncology (2024)

Mohamed A. GoudaBettzy StephenYanyan TianAnas AlshawaDilichukwu O. Chudy OnwugajeAya AlbittarYali YangAbdulrazzak ZarifaBulent YilmazSerdar GursesAshabari SprengerMohamed H. DerbalaAmanda BrinkJeffrey Andrew HowJustin MoyersSarina A. Piha-PaulDavid S. HongFunda Meric-BernstamSapna P. PatelIsabella Glitza Oliva

metastasisphase ib studytumor heterogeneitytumor targetinganti-cancer agentsdermatologycancer researchimmune checkpoint inhibitorssurgical oncologytumor suppressorscancer immunotherapyimmunotherapyimmunologyradiation oncologymetastatic melanomacancer discoveryoncologyoncogenesmedicinal researchcellular therapy

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. The Oncologist (2023)

Mehmet AltanFelipe SotoLinda L ZhongFechukwu O AkhmedzhanovNathaniel R WilsonAbdulrazzak ZarifaAya A AlbittarVincent YangJeff LewisWaree RinsurongkawongJ Jack LeeVadeerat RinsurongkawongJianjun ZhangDon L GibbonsAra A VaporciyanKristofer JenningsFareed KhawajaSaadia A FaizVickie R ShannonGirish ShroffMyrna C B GodoyNaval G DaverSaumil GandhiTito R MendozaAung NaingCarrie Daniel-MacDougallJohn V HeymachAjay Sheshadri

clinical evidenceclinical epidemiologycancer riskmedicinepulmonary diseasescancer carecancer managementsingle center experiencehealth sciencesclinical mycologycancer researchcancer immunotherapycheckpoint inhibitorslung cancermedical mycologypharmacologythoracic oncologyoncologyrespiratory medicinemedicinal researchrisk factors

Pneumonitis After Immune Checkpoint Inhibitor Therapies in Patients With Acute Myeloid Leukemia: A Retrospective Cohort Study. Cancer (2022)

Ajay SheshadriAlberto A. GoizuetaVickie R. ShannonDavid LondonGuillermo Garcia‐ManeroHagop M. KantarjianFarhad Ravandi‐KashaniTapan M. KadiaMarina Y. KonoplevaCourtney D. DiNardoSherry PierceAbdulrazzak ZarifaAya A. AlbittarLinda L. ZhongFechukwu O. AkhmedzhanovMuhammad H. ArainMansour AlfayezAhmad AlotaibiMehmet AltanAung NaingTito R. MendozaMyrna C. B. GodoyGirish ShroffSang T. KimSaadia A. FaizDimitrios P. KontoyiannisFareed KhawajaKristofer JenningsNaval G. Daver

hematological malignanciesemergency medicineepidemiologyclinical epidemiologymedicineoutcomes researchcancer carecancer managementacute myeloid leukemiacancer biologycancer researchpreventive medicinecancer treatmentmedical mycologyclinical immunologypharmacotherapyclinical researchoncologymedicinal research

Outcomes of Changing Systemic Therapy in Patients With Relapsed Breast Cancer and 1 to 3 Brain Metastases. npj Breast Cancer (2021)

Omar AlhalabiZaid SoomroRyan SunElshad HasanovAya AlbittarDebu TripathyVicente ValeroNuhad K. Ibrahim

medicineoutcomes researchpharmacologymetastasiscancer caresystemic therapycancer managementradiation oncologycancer researchsurgical oncologyrelapsed breast cancerbrain metastasesbreast canceroncologymedicinal researchcancer treatmentbreast oncology

Supportive Care for the Prevention of Nausea, Vomiting and Anorexia in a Phase 1B Study of Selinexor in Advanced Cancer Patients: An Exploratory Study. Investigational New Drugs (2021)

Rony DevLinda L. ZhongAbdulrazzak ZarifaAya A. AlbittarLaura RubinSuyu LiuTimothy A. YapShalini DalalDavid HuiDaniel D. KarpApostolia M. TsimberidouSarina A. Piha-PaulJordi Rodon AhnertSiqing FuFunda Meric-BernstamAung Naing

medicinestrategic studiespharmacologysymptom managementradiation oncologyexploratory studyadvanced cancer patientsoncologyclinical researchclinical investigationsupportive care

Immunotherapy for Melanoma. Advances in experimental medicine and biology (2020)

immunologydermatologymelanomacancer immunotherapyoncologycancer cellscellular therapytherapeutic vaccinesimmunotherapy

Incidence of Pneumonitis After Immune Checkpoint Inhibitor Therapy in Patients With Acute Myeloid Leukemia. (2020)

immunologyhematological malignanciesmedicineleukemiamyeloid neoplasiahematologyimmune checkpoint inhibitorsoncologyacute myeloid leukemiajama oncologypathologyimmunotherapy

Systemic Therapy for Patients With Breast Cancer and One to Three Brain Metastases (Bm).. Journal of Clinical Oncology (2020)

neurologymetastasiscancer caregliomassystemic therapyradiation oncologybrain tumor researchbrain metastasesbreast canceroncologyneuro-oncologyradiation therapycancer treatmentbreast oncology

Cardiac Toxicities of Anticancer Treatments. Current Opinion in Cardiology (2019)

cardiologyanticancer treatmentspharmacologycardiovascular pharmacologycardiovascular researchpharmacotherapycardiovascular toxicityoncologycardiovascular disease

1
10 / page

Aya Albittar

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hematopoietic Biology And Malignancy

NoneAya Albittar is currently serving as a Hematopoietic Biology And Malignancy faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Aya Albittar

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase Ib Study of Selinexor in Combination With Pembrolizumab in Patients With Metastatic Melanoma. Journal of Immunotherapy and Precision Oncology (2024)

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. The Oncologist (2023)

Pneumonitis After Immune Checkpoint Inhibitor Therapies in Patients With Acute Myeloid Leukemia: A Retrospective Cohort Study. Cancer (2022)

Outcomes of Changing Systemic Therapy in Patients With Relapsed Breast Cancer and 1 to 3 Brain Metastases. npj Breast Cancer (2021)

Omar AlhalabiZaid SoomroRyan SunElshad HasanovAya AlbittarDebu TripathyVicente ValeroNuhad K. Ibrahim

Supportive Care for the Prevention of Nausea, Vomiting and Anorexia in a Phase 1B Study of Selinexor in Advanced Cancer Patients: An Exploratory Study. Investigational New Drugs (2021)

medicinestrategic studiespharmacologysymptom managementradiation oncologyexploratory studyadvanced cancer patientsoncologyclinical researchclinical investigationsupportive care

Immunotherapy for Melanoma. Advances in experimental medicine and biology (2020)

immunologydermatologymelanomacancer immunotherapyoncologycancer cellscellular therapytherapeutic vaccinesimmunotherapy

Incidence of Pneumonitis After Immune Checkpoint Inhibitor Therapy in Patients With Acute Myeloid Leukemia. (2020)

immunologyhematological malignanciesmedicineleukemiamyeloid neoplasiahematologyimmune checkpoint inhibitorsoncologyacute myeloid leukemiajama oncologypathologyimmunotherapy

Systemic Therapy for Patients With Breast Cancer and One to Three Brain Metastases (Bm).. Journal of Clinical Oncology (2020)

neurologymetastasiscancer caregliomassystemic therapyradiation oncologybrain tumor researchbrain metastasesbreast canceroncologyneuro-oncologyradiation therapycancer treatmentbreast oncology

Cardiac Toxicities of Anticancer Treatments. Current Opinion in Cardiology (2019)

cardiologyanticancer treatmentspharmacologycardiovascular pharmacologycardiovascular researchpharmacotherapycardiovascular toxicityoncologycardiovascular disease

1
10 / page